4.5 Article

Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry

Journal

BREAST CANCER RESEARCH AND TREATMENT
Volume 168, Issue 3, Pages 703-712

Publisher

SPRINGER
DOI: 10.1007/s10549-017-4638-1

Keywords

Breast neoplasms; Polygenic risk score; Women of African ancestry; Flip-flop

Categories

Funding

  1. American Cancer Society [MRSG-13-063-01-TBG, CRP-10-119-01-CCE]
  2. National Cancer Institute [CA142996, CA161032]
  3. Susan G. Komen for the Cure
  4. Breast Cancer Research Foundation
  5. University of Chicago Center for Global Health Postdoctoral Research Fellowship

Ask authors/readers for more resources

Few studies have evaluated the performance of existing breast cancer risk prediction models among women of African ancestry. In replication studies of genetic variants, a change in direction of the risk association is a common phenomenon. Termed flip-flop, it means that a variant is risk factor in one population but protective in another, affecting the performance of risk prediction models. We used data from the genome-wide association study (GWAS) of breast cancer in the African diaspora (The Root consortium), which included 3686 participants of African ancestry from Nigeria, USA, and Barbados. Polygenic risk scores (PRSs) were constructed from the published odds ratios (ORs) of four sets of susceptibility loci for breast cancer. Discrimination capacity was measured using the area under the receiver operating characteristic curve (AUC). Flip-flop phenomenon was observed among 30 similar to 40% of variants across studies. Using the 34 variants with consistent directionality among previous studies, we constructed a PRS with AUC of 0.531 (95% confidence interval [CI]: 0.512-0.550), which is similar to the PRS using 93 variants and ORs from European ancestry populations (AUC = 0.525, 95% CI: 0.506-0.544). Additionally, we found the 34-variant PRS has good discriminative accuracy in women with family history of breast cancer (AUC = 0.586, 95% CI: 0.532-0.640). We found that PRS based on variants identified from prior GWASs conducted in women of European and Asian ancestries did not provide a comparable degree of risk stratification for women of African ancestry. Further large-scale fine-mapping studies in African ancestry populations are desirable to discover population-specific genetic risk variants.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study

Kelly M. Morgan, Jada G. Hamilton, Heather Symecko, Daniella Kamara, Colby Jenkins, Jenny Lester, Kelsey Spielman, Lydia E. Pace, Camila Gabriel, Jeffrey D. Levin, Prince Rainier Tejada, Anthony Braswell, Vanessa Marcell, Temima Wildman, Bryan Devolder, Robin Camhi Baum, Jeremy N. Block, Yuri Fesko, Kylin Boehler, Victoria Howell, Jacob Heitler, Mark E. Robson, Katherine L. Nathanson, Nadine Tung, Beth Y. Karlan, Susan M. Domchek, Judy E. Garber, Kenneth Offit

Summary: This study aimed to evaluate the uptake and follow-up of internet-assisted population genetic testing (GT) for BRCA1/2 Ashkenazi Jewish founder pathogenic variants (AJPVs). The study found that internet-enabled outreach can expand access to targeted GT and promote increased cancer screening among AJPV carriers.

GENETICS IN MEDICINE (2022)

Article Oncology

Mutational spectrum of breast cancer susceptibility genes among women ascertained in a cancer risk clinic in Northeast Brazil

Gabriela E. S. Felix, Rodrigo Santa Cruz Guindalini, Yonglan Zheng, Tom Walsh, Elisabeth Sveen, Taisa Manuela Machado Lopes, Juliana Cortes, Jing Zhang, Polyanna Carozo, Irlania Santos, Thais Ferreira Bonfim, Bernardo Garicochea, Maria Betania Pereira Toralles, Roberto Meyer, Eduardo Martins Netto, Kiyoko Abe-Sandes, Mary-Claire King, Ivana Lucia de Oliveira Nascimento, Olufunmilayo Olopade

Summary: The study reveals the prevalence and heterogeneous spectrum of pathogenic variants among self-reported African-descended women in Northeast Brazil, with high-risk genes including BRCA1, BRCA2, PALB2, and TP53.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Article Cell Biology

A human breast atlas integrating single-cell proteomics and transcriptomics

G. Kenneth Gray, Carman Man-Chung Li, Jennifer M. Rosenbluth, Laura M. Selfors, Nomeda Girnius, Jia-Ren Lin, Ron C. J. Schackmann, Walter L. Goh, Kaitlin Moore, Hana K. Shapiro, Shaolin Mei, Kurt D'Andrea, Katherine L. Nathanson, Peter K. Sorger, Sandro Santagata, Aviv Regev, Judy E. Garber, Deborah A. Dillon, Joan S. Brugge

Summary: This study presents a high-resolution breast atlas by integrating various techniques, defining different types of breast cells and their associations with breast cancer risk factors. A subset of cells associated with basal-like breast cancer was identified, and molecular factors regulating cell proportions were identified.

DEVELOPMENTAL CELL (2022)

Article Biochemistry & Molecular Biology

Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach

Guimin Gao, Fangyuan Zhao, Thomas U. Ahearn, Kathryn L. Lunetta, Melissa A. Troester, Zhaohui Du, Temidayo O. Ogundiran, Oladosu Ojengbede, William Blot, Katherine L. Nathanson, Susan M. Domchek, Barbara Nemesure, Anselm Hennis, Stefan Ambs, Julian McClellan, Mark Nie, Kimberly Bertrand, Gary Zirpoli, Song Yao, Andrew F. Olshan, Jeannette T. Bensen, Elisa Bandera, Sarah Nyante, David Conti, Michael F. Press, Sue A. Ingles, Esther M. John, Leslie Bernstein, Jennifer J. Hu, Sandra L. Deming-Halverson, Stephen J. Chanock, Regina G. Ziegler, Jorge L. Rodriguez-Gil, Lara E. Sucheston-Campbell, Dale P. Sandler, Jack A. Taylor, Cari M. Kitahara, Katie M. O'Brien, Manjeet K. Bolla, Joe Dennis, Alison M. Dunning, Douglas F. Easton, Kyriaki Michailidou, Paul D. P. Pharoah, Qin Wang, Jonine Figueroa, Richard Biritwum, Ernest Adjei, Seth Wiafe, Christine B. Ambrosone, Wei Zheng, Olufunmilayo Olopade, Montserrat Garcia-Closas, Julie R. Palmer, Christopher A. Haiman, Dezheng Huo

Summary: Optimal polygenic risk scores (PRSs) have been developed to improve breast cancer risk prediction in women of African ancestry (AA). The combination of PRSs built in the AA training dataset and a previously developed PRS in women of European ancestry significantly improves the prediction of breast cancer risk in AA women.

HUMAN MOLECULAR GENETICS (2022)

Article Multidisciplinary Sciences

Detection of germline variants in Brazilian breast cancer patients using multigene panel testing

Rodrigo Santa Cruz Guindalini, Danilo Vilela Viana, Joao Paulo Fumio Whitaker Kitajima, Vinicius Marques Rocha, Rossana Veronica Mendoza Lopez, Yonglan Zheng, Erika Freitas, Fabiola Paoli Mendes Monteiro, Andre Valim, David Schlesinger, Fernando Kok, Olufunmilayo Olopade, Maria Aparecida Azevedo Koike Folgueira

Summary: Genetic diversity of germline variants in breast cancer predisposition genes was explored in a study of 1663 Brazilian patients. Pathogenic/likely pathogenic variants were found in 20.1% of participants, with TP53, BRCA1, and BRCA2 being the most commonly mutated genes. The TP53 R337H variant was strongly associated with breast cancer risk, while MUTYH variants showed no association. About 46.1% of patients had variants of uncertain significance (VUS).

SCIENTIFIC REPORTS (2022)

Article Oncology

Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk

Chiara Grasso, Maja Popovic, Elena Isaevska, Fulvio Lazzarato, Valentina Fiano, Daniela Zugna, John Pluta, Benita Weathers, Kurt D'Andrea, Kristian Almstrup, Lynn Anson-Cartwright, D. Timothy Bishop, Stephen J. Chanock, Chu Chen, Victoria K. Cortessis, Marlene D. Dalgaard, Siamak Daneshmand, Alberto Ferlin, Carlo Foresta, Megan N. Frone, Marija Gamulin, Jourik A. Gietema, Mark H. Greene, Tom Grotmol, Robert J. Hamilton, Trine B. Haugen, Russ Hauser, Robert Karlsson, Lambertus A. Kiemeney, Davor Lessel, Patrizia Lista, Ragnhild A. Lothe, Chey Loveday, Coby Meijer, Kevin T. Nead, Jeremie Nsengimana, Rolf I. Skotheim, Clare Turnbull, David J. Vaughn, Fredrik Wiklund, Tongzhang Zheng, Andrea Zitella, Stephen M. Schwartz, Katherine A. McGlynn, Peter A. Kanetsky, Katherine L. Nathanson, Lorenzo Richiardi

Summary: This study found that genetic variants within the MTHFR gene are associated with the risk of testicular germ cell tumors (TGCT), potentially affecting the establishment of DNA methylation patterns. This finding suggests that the pathogenesis of TGCT may be related to the status of the folate cycle, and this relation could be partly due to hereditary factors.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Biochemistry & Molecular Biology

An enhancer variant associated with breast cancer susceptibility in Black women regulates TNFSF10 expression and antitumor immunity in triple-negative breast cancer

Yoo Jane Han, Jing Zhang, Ashley Hardeman, Margaret Liu, Olga Karginova, Roger Romero, Galina F. Khramtsova, Yonglan Zheng, Dezheng Huo, Olufunmilayo Olopade

Summary: Women of African ancestry have the highest mortality from triple-negative breast cancer (TNBC). The SNP rs13074711 regulates TNFSF10 expression in TNBC cells, and its genotype is associated with TNFSF10 expression in breast tumors. TNFSF10 expression is consistently lower in African Americans compared with European Americans. Loss of TNFSF10 decreases apoptosis of TNBC cells in response to type I interferons and poly(I:C). TNFSF10 plays an important role in the regulation of antiviral immune responses in TNBC.

HUMAN MOLECULAR GENETICS (2023)

Article Multidisciplinary Sciences

Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer

Ashley A. Hardeman, Yoo Jane Han, Tatyana A. Grushko, Jeffrey Mueller, Maria J. Gomez, Yonglan Zheng, Olufunmilayo I. Olopade

Summary: This study found that MELK gene expression is highly upregulated in aggressive forms of breast cancer, particularly in basal-like breast cancer (BLBC). The increase in MELK expression appears to be driven by gene copy number gains rather than epigenetic modifications. The findings suggest that MELK overexpression and copy number gains could be potential diagnostic and prognostic markers for identifying patients with more aggressive breast cancer.

PLOS ONE (2022)

Article Genetics & Heredity

Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood

Kara N. Maxwell, Vishal Patel, Kevin T. Nead, Shana Merrill, Dana Clark, Qinqin Jiang, Bradley Wubbenhorst, Kurt D'Andrea, Roger B. Cohen, Susan M. Domchek, Jennifer J. D. Morrissette, Roger A. Greenberg, Daria Babushok, Katherine L. Nathanson

Summary: Inherited biallelic pathogenic variants (PVs) in BRCA2 can cause Fanconi Anemia complementation group D1 (FA-D1). Our study identified a case where the individual with biallelic BRCA2 PVs did not have bone marrow failure but developed multiple cancers. This expands the clinical spectrum of FA-D1 and emphasizes the importance of early recognition of this syndrome in families.

CLINICAL GENETICS (2023)

Article Genetics & Heredity

ARTICLE Impact of integrating genomic data into the electronic health record on genetics care delivery

Kelsey S. Lau-Min, Danielle McKenna, Stephanie Byers Asher, Tanya Bardakjian, Colin Wollack, Joseph Bleznuck, Daniel Biros, Arravinth Anantharajah, Dana F. Clark, Courtney Condit, Jessica E. Ebrahimzadeh, Jessica M. Long, Jacquelyn Powers, Anna Raper, Anna Schoenbaum, Michael Feldman, Lauren Steinfeld, Sony Tuteja, Christine VanZandbergen, Susan M. Domchek, Marylyn D. Ritchie, Jeffrey Landgraf, Jessica Chen, Katherine L. Nathanson

Summary: This study describes the successful integration of genetic testing orders and results with discrete genetic data in the electronic health record (EHR) through the PennChart Genomics Initiative (PGI) at the University of Pennsylvania. The PGI has collaborated with 4 genetic testing laboratories to create 420 unique computerized genetic testing orders in the EHR. Results show that using the EHR significantly reduces the time spent on ordering and managing genetic results compared to using online laboratory-specific portals. Key informant interviews highlight the importance of multidisciplinary collaboration and institutional buy-in for the success of the PGI's efforts to integrate genomic medicine into the EHR.

GENETICS IN MEDICINE (2022)

Article Oncology

NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects

Sami Belhadj, Aliya Khurram, Chaitanya Bandlamudi, Guillermo Palou-Marquez, Vignesh Ravichandran, Zoe Steinsnyder, Temima Wildman, Amanda Catchings, Yelena Kemel, Semanti Mukherjee, Benjamin Fesko, Kanika Arora, Miika Mehine, Sita Dandiker, Aalin Izhar, John Petrini, Susan Domchek, Katherine L. Nathanson, Jamie Brower, Fergus Couch, Zsofia Stadler, Mark Robson, Michael Walsh, Joseph Vijai, Michael Berger, Fran Supek, Rachid Karam, Sabine Topka, Kenneth Offit

Summary: Through sequencing analysis of matched germline and somatic DNA samples from 34,046 patients, 32 pathogenic variants of NBN were identified. Patients carrying these variants showed increased loss of wild-type allele in lung and pancreatic tumors. Functional studies confirmed the important role of NBN in a broad spectrum of cancers.

CLINICAL CANCER RESEARCH (2023)

Article Oncology

Systemic Inflammation Indices and Association with Prostate Cancer Survival in a Diverse Patient Cohort

Maeve Bailey-Whyte, Tsion Z. Minas, Tiffany H. Dorsey, Cheryl J. Smith, Christopher A. Loffredo, Stefan Ambs

Summary: This study investigates the association between four systemic inflammation indices and prostate cancer mortality. It finds that three of these indices are significantly associated with all-cause and prostate cancer-specific mortality among all men and African American men, suggesting that inflammation indices could be predictors of prostate cancer mortality.

CANCERS (2023)

Article Biochemistry & Molecular Biology

Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells

Robert Y. S. Cheng, Sandra Burkett, Stefan Ambs, Terry Moody, David A. A. Wink, Lisa A. A. Ridnour

Summary: The small signaling molecule nitric oxide (NO) is associated with chronic inflammation and cancer. NO can have both protective and damaging effects on cells depending on its concentration and exposure time. In this study, chronic exposure to NO was found to cause altered phenotypes in breast epithelial cells, including changes in cellular morphology, genomic stability, and RNA and protein expression. These altered phenotypes were associated with malignant characteristics, such as increased expression of cancer stem cell marker CD44 and enhanced motility.

BIOMOLECULES (2023)

Article Medicine, General & Internal

Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer

Fangyuan Zhao, Minoru Miyashita, Masaya Hattori, Toshio Yoshimatsu, Frederick Howard, Kristiyana Kaneva, Ryan Jones, Joshua S. K. Bell, Gini F. Fleming, Nora Jaskowiak, Rita Nanda, Yonglan Zheng, Dezheng Huo, Olufunmilayo I. Olopade

Summary: This study investigated racial disparities in achieving pathologic complete response (pCR) after neoadjuvant chemotherapy in breast cancer patients and identified factors contributing to these disparities. The study found that Black patients had lower odds of achieving pCR compared to White patients in the hormone receptor-negative/ERBB2+ subtype, and they were more likely to have MAPK pathway alterations, a potential mechanism of anti-ERBB2 therapy resistance. Additionally, significant differences in tumor mutational burden and somatic alterations in several genes were observed between primary and residual tumors.

JAMA NETWORK OPEN (2023)

Article Oncology

Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations

Minoru Miyashita, Joshua S. K. Bell, Stephane Wenric, Ezgi Karaesmen, Brooke Rhead, Matthew Kase, Kristiyana Kaneva, Francisco M. M. de la Vega, Yonglan Zheng, Toshio F. F. Yoshimatsu, Galina Khramtsova, Fang Liu, Fangyuan Zhao, Frederick M. M. Howard, Rita Nanda, Nike Beaubier, Kevin P. P. White, Dezheng Huo, Olufunmilayo I. I. Olopade

Summary: This study compared the molecular features of HR+/HER2- breast cancer and TNBC subtypes between patients of African and European ancestries, and found significant differences in genetic mutations, gene expression, and transcriptional signatures. These findings contribute to promoting equity in personalized cancer treatment by providing more accurate treatment strategies for diverse populations.

BREAST CANCER RESEARCH (2023)

No Data Available